Therapeutic Potential of Plant Phenolic Acids Combating Cancer Drug Resistance.

Prerana Kapil, Arpan Kumar Tripathi, Rashmi Saxena Pal, Sachin Kumar Singh, Kuldeep Singh, Divya Jain, Mvnl Chaitanya
{"title":"Therapeutic Potential of Plant Phenolic Acids Combating Cancer Drug Resistance.","authors":"Prerana Kapil, Arpan Kumar Tripathi, Rashmi Saxena Pal, Sachin Kumar Singh, Kuldeep Singh, Divya Jain, Mvnl Chaitanya","doi":"10.2174/012772574X350275241230053727","DOIUrl":null,"url":null,"abstract":"<p><p>Despite notable progress in treatment modalities, cancer continues to be a prom-inent cause of death globally. Chemotherapy is the main method used to treat cancer, and chemotherapeutic medications are categorized according to how they work. Nevertheless, the issue of multidrug resistance (MDR) is a significant obstacle, impacting almost 90% of cancer patients who receive chemotherapy or innovative targeted medicines. MDR pro-cesses involve the quick metabolism of foreign substances, the accelerated removal of drugs from cells, the stimulation of growth hormones, the enhancement of DNA repair ability, and the influence of genetic variables. Recent studies have mostly concentrated on studying the anticancer effects of dietary phytoconstituents as a possible remedy for overcoming multidrug resistance (MDR). Various bioactive compounds, such as phenolic acids, phe-nylpropanoids, flavonoids, stilbenes, terpenoids, and organo-sulfur compounds, have shown potential in fighting cancer. It is worth mentioning that a number of phenylpro-panoids are now being tested in clinical trials to evaluate their effectiveness in fighting cancer. This review presents a comprehensive summary of the existing knowledge regard-ing dietary phytoconstituents as possible agents for treating cancer, particularly their ability to overcome MDR. This discussion will focus on the mechanisms by which these com-pounds work, as well as the data from both preclinical and clinical studies. Additionally, we have explored the potential future applications of these compounds in the development of cancer therapeutics.</p>","PeriodicalId":74644,"journal":{"name":"Recent advances in food, nutrition & agriculture","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Recent advances in food, nutrition & agriculture","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/012772574X350275241230053727","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Despite notable progress in treatment modalities, cancer continues to be a prom-inent cause of death globally. Chemotherapy is the main method used to treat cancer, and chemotherapeutic medications are categorized according to how they work. Nevertheless, the issue of multidrug resistance (MDR) is a significant obstacle, impacting almost 90% of cancer patients who receive chemotherapy or innovative targeted medicines. MDR pro-cesses involve the quick metabolism of foreign substances, the accelerated removal of drugs from cells, the stimulation of growth hormones, the enhancement of DNA repair ability, and the influence of genetic variables. Recent studies have mostly concentrated on studying the anticancer effects of dietary phytoconstituents as a possible remedy for overcoming multidrug resistance (MDR). Various bioactive compounds, such as phenolic acids, phe-nylpropanoids, flavonoids, stilbenes, terpenoids, and organo-sulfur compounds, have shown potential in fighting cancer. It is worth mentioning that a number of phenylpro-panoids are now being tested in clinical trials to evaluate their effectiveness in fighting cancer. This review presents a comprehensive summary of the existing knowledge regard-ing dietary phytoconstituents as possible agents for treating cancer, particularly their ability to overcome MDR. This discussion will focus on the mechanisms by which these com-pounds work, as well as the data from both preclinical and clinical studies. Additionally, we have explored the potential future applications of these compounds in the development of cancer therapeutics.

植物酚酸对抗癌症耐药的治疗潜力。
尽管在治疗方式方面取得了显著进展,但癌症仍然是全球主要的死亡原因。化疗是治疗癌症的主要方法,化疗药物根据其作用方式进行分类。然而,多药耐药(MDR)问题是一个重大障碍,影响了几乎90%接受化疗或创新靶向药物治疗的癌症患者。MDR过程包括异物的快速代谢、药物从细胞中加速清除、生长激素的刺激、DNA修复能力的增强以及遗传变量的影响。最近的研究主要集中在研究膳食植物成分的抗癌作用,作为克服多药耐药(MDR)的可能补救措施。各种生物活性化合物,如酚酸、苯基丙素、类黄酮、二苯乙烯、萜类和有机硫化合物,已经显示出抗癌的潜力。值得一提的是,一些苯原类panoid目前正在临床试验中进行测试,以评估它们在抗癌方面的有效性。这篇综述全面总结了关于膳食植物成分作为治疗癌症的可能药物的现有知识,特别是它们克服耐多药的能力。本讨论将集中于这些化合物的作用机制,以及临床前和临床研究的数据。此外,我们还探索了这些化合物在癌症治疗药物开发中的潜在未来应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.70
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信